53 related articles for article (PubMed ID: 29161928)
1. Imparting aromaticity to 2-pyridone derivatives by
Abdelaziz ME; El-Miligy MMM; Fahmy SM; Abu-Serie MM; Hazzaa AA; Mahran MA
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2304044. PubMed ID: 38230430
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and bioevaluation of SOS1 PROTACs derived from pyrido[2,3-d]pyrimidin-7-one-based SOS1 inhibitor.
Wang K; Zhou Z; Ma X; Xu J; Xu W; Zhou G; Zhou C; Li H; Zheng M; Zhang S; Xu T
Bioorg Med Chem Lett; 2024 Jul; 107():129780. PubMed ID: 38714262
[TBL] [Abstract][Full Text] [Related]
3. What doesn't fit is made to fit: Pim-1 kinase adapts to the configuration of stilbene-based inhibitors.
Hochban PMM; Heyder L; Heine A; Diederich WE
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2400094. PubMed ID: 38631036
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2).
Reddy MV; Akula B; Jatiani S; Vasquez-Del Carpio R; Billa VK; Mallireddigari MR; Cosenza SC; Venkata Subbaiah DR; Bharathi EV; Pallela VR; Ramkumar P; Jain R; Aggarwal AK; Reddy EP
Bioorg Med Chem; 2016 Feb; 24(4):521-44. PubMed ID: 26762835
[TBL] [Abstract][Full Text] [Related]
5. Virtual Screening and Design with Machine Intelligence Applied to Pim-1 Kinase Inhibitors.
Schneider P; Welin M; Svensson B; Walse B; Schneider G
Mol Inform; 2020 Sep; 39(9):e2000109. PubMed ID: 33448694
[TBL] [Abstract][Full Text] [Related]
6. WLB-87848, a Selective σ
Christmann U; Garriga L; Llorente AV; Díaz JL; Pascual R; Bordas M; Dordal A; Porras M; Yeste S; Reinoso RF; Vela JM; Almansa C
J Med Chem; 2024 Jun; 67(11):9150-9164. PubMed ID: 38753759
[TBL] [Abstract][Full Text] [Related]
7. Generation of 500-member library of 10-alkyl-2-R(1),3-R(2)-4,10-dihydrobenzo[4,5]imidazo[1,2-alpha]pyrimidin-4-ones.
Sirko SM; Gorobets NY; Musatov VI; Desenko SM
Molecules; 2009 Dec; 14(12):5223-34. PubMed ID: 20032888
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of New Pyridothienopyrimidine Derivatives as Antibacterial Agents and
Mohi El-Deen EM; Abd El-Meguid EA; Karam EA; Nossier ES; Ahmed MF
Antibiotics (Basel); 2020 Oct; 9(10):. PubMed ID: 33066400
[TBL] [Abstract][Full Text] [Related]
9.
Markou A; Tzanikou E; Strati A; Zavridou M; Mastoraki S; Bournakis E; Lianidou E
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397108
[No Abstract] [Full Text] [Related]
10. Synthesis and Antibacterial Activities of Different Five-Membered Heterocyclic Rings Incorporated with Pyridothienopyrimidine.
Zayda MG; Abdel-Rahman AA; El-Essawy FA
ACS Omega; 2020 Mar; 5(11):6163-6168. PubMed ID: 32226900
[TBL] [Abstract][Full Text] [Related]
11. Pim kinase inhibitory and antiproliferative activity of a novel series of meridianin C derivatives.
More KN; Jang HW; Hong VS; Lee J
Bioorg Med Chem Lett; 2014 Jun; 24(11):2424-8. PubMed ID: 24775304
[TBL] [Abstract][Full Text] [Related]
12. PIM kinase inhibitors: Structural and pharmacological perspectives.
Asati V; Mahapatra DK; Bharti SK
Eur J Med Chem; 2019 Jun; 172():95-108. PubMed ID: 30954777
[TBL] [Abstract][Full Text] [Related]
13. Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties.
Bozorov K; Zhao JY; Elmuradov B; Pataer A; Aisa HA
Eur J Med Chem; 2015 Sep; 102():552-73. PubMed ID: 26312434
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new pyridothienopyrimidinone and pyridothienotriazolopyrimidine derivatives as pim-1 inhibitors.
El-Nassan HB; Naguib BH; Beshay EA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):58-66. PubMed ID: 29161928
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of new pyridothienopyrimidinone derivatives as Pim-1 inhibitors.
Naguib BH; El-Nassan HB; Abdelghany TM
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):457-467. PubMed ID: 28097906
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
Giraud F; Akué-Gédu R; Nauton L; Candelon N; Debiton E; Théry V; Anizon F; Moreau P
Eur J Med Chem; 2012 Oct; 56():225-36. PubMed ID: 22982527
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
